Stock ABBV ABBVIE INC.
Add to a list
To use this feature you must be a member
Log inSign up

News AbbVie Inc.

Equities

ABBV

US00287Y1091

Market Closed - Nyse
Other stock markets
 04:00:04 2024-05-16 pm EDT 		5-day change 1st Jan Change
164.3 USD +0.33% Intraday chart for AbbVie Inc. +2.45% +6.04%
May. 15 Transcript : AbbVie Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM
May. 15 Medincell: share price falls after disappointing clinical study CF

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : AbbVie Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM
Medincell: share price falls after disappointing clinical study
CF
AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders
MT
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
PR
Medincell: share price rises on resumption of trading
CF
AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine
MT
Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190
MT
QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults
AQ
Health Canada Approves QULIPTA for the Preventive Treatment of Chronic Migraine in Adults
CI
Medincell: listing suspended pending a press release
CF
AbbVie to Present at the Bank of America Securities Healthcare Conference
PR
AbbVie : Reinforces Commitment to Science and Innovation with a €150 million Euro Investment in New Cutting-Edge Research and Development Facility in Germany
PU
Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent
MT
Health Care Up on Growth Optimism -- Health Care Roundup
DJ
BMO Capital Cuts Price Target on AbbVie to $180 From $195, Maintains Outperform Rating
MT
Morgan Stanley Adjusts AbbVie's Price Target to $191 From $196
MT
Barclays Adjusts Price Target on AbbVie to $187 From $195
MT
Health Care Flat After Strong Earnings Week -- Health Care Roundup
DJ
News Highlights : Top Company News of the Day - Friday at 5 PM ET
DJ
News Highlights : Top Company News of the Day - Friday at 7 PM ET
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABBV Stock
  4. News AbbVie Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW